PETITION CLOSED

  • The time period for signing this petition has ended.
DEMAND IVIG FOR TREATMENT OF ALZHEIMER'S NOW
  1. Signatures
    254 out of 500
    Petitioning
    1. The President of the United States (+ 16 others)
      Petitioning
      close
      • The President of the United States
      • The U.S. Senate
      • The U.S. House of Representatives
      • Sen. Mitch McConnell (KY)
      • Sen. Richard Durbin (IL)
      • Sen. Charles Schumer (NY)
      • Sen. Barbara Boxer (CA)
      • Sen. Harry Reid (NV)
      • Sen. Debbie Stabenow (MI)
      • Rep. Debbie Wasserman Schultz (FL-20)
      • Rep. Nancy Pelosi (CA-08)
      • Rep. Steny Hoyer (MD-05)
      • Rep. John Boehner (OH-08)
      • Sen. John Rockefeller (WV)
      • Sen. Joseph Manchin (WV)
      • CEO, BAXTER Healthcare (Robert Parkinson, JR)
      • Secretary of Health and Human Services (Kathleen Sebelius)
  2. Created By
    Chere Hallahan
    Ashland, United States Minor Outlying Islands
About this Petition Petition Letter Petition Updates

Clinical trials sponsored by Baxter Healthcare in conjunction with the NIH using bi-weekly infusions of Gammaglobulin has completed a third phase trial. Caregivers and clinical professionals have seen a DRAMATIC change in Alzheimer's patients who are believed to have received the infusions of Gammaglobulin. Improvements were observed in quality of life, daily functioning and activities, appetite, grooming and other life activities that are often disrupted and often halted by the progression of Alzheimer's. At the completion of each participants' trial, the infusions were halted by Baxter and were not offered to the participants as an option to continue use, even though personal observations indicated definite improvements. Months after the completion of the trial and after infusions were stopped, the original Alzheimer's symptoms may have OR have returned in at least one or some of the participants in the study. Baxter must take responsibility and allow these persons the choice to continue these infusions if they choose for the lifetime of the patient at no charge. Baxter, the NIH and the FDA are wasting time with this deadly, cruel disease which has now inflicted more then 5.3 million Americans alone. Tell Baxter, the NIH and the FDA to get IVIG (infusions of Gammaglobulin) approved and on the market at an affordable price for all persons with Alzheimer's disease to have and use for the treatment of and the slowing of the progression of Alzheimer's disease.

Why People Are Signing
Recent Signatures

TREAT ALZHEIMER'S WITH IGIV. GIVE LIFETIME INFUSIONS TO TRIAL PARTICIPANTS

Greetings,

I just signed the following petition addressed to: Baxter CEO Robert Parkinson, JR.

----------------
TREAT ALZHEIMER'S WITH IGIV. GIVE LIFETIME INFUSIONS TO TRIAL PARTICIPANTS

Clinical trials sponsored by Baxter in conjunction with the NIH using bi-weekly infusions of Gammaglobulin has been underway and in it's third phase. Caregivers and clinical professionals have seen a dramatic change in Alzheimer's patients who are believed to have received the infusions of Gammaglobulin. Improvements were observed in quality of life, daily functioning and activities, appetite, grooming and other life activities that are often disrupted and often halted by the progression of Alzheimer's. At the completion of each participants' trial, the infusions were halted by Baxter and were not offered to the participants as an option to continue use, even though personal observations indicated definite improvements. Months after the completion of the trial and after infusions were stopped, the original Alzheimer's symptoms may have OR have returned in at least one or some of the participants in the study. Baxter must take responsibility and allow these persons the choice to continue these infusions if they choose for the lifetime of the patient at no charge. Baxter, the NIH and the FDA are wasting time with this deadly, cruel disease which has now inflicted more then 5.5 million Americans alone. Let's tell Baxter, the NIH and the FDA to get IVIG (infusions of Gammaglobulin) approved and on the market at an affordable price for all persons with Alzheimer's disease to have and use for the treatment of and the slowing of the progression of Alzheimer's disease.
----------------

Sincerely,

[Your name]

Press Inquiries